ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study

Study limitation reported by the research below: “Cohorts were not randomized — participants self-selected their PrEP modality, so unmeasured confounding (e.g., motivation, baseline risk behavior) may partly explain the large incidence differences between groups.”

Papers